Researchers have found that AI can detect the signs of prostate cancer in 80% of samples that had been missed by pathologists. "The study has been nicknamed the 'missed study,'" a co-author said. For this, the AI tool first analysed samples from men initially assessed as negative, assuming there must be some abnormality, as they later developed aggressive prostate cancer.